The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Open accessAbstract
Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation. RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology in vivo to identify novel tumour suppressor genes. Here we developed a method for identifying novel cancer targets via negative-selection RNAi screening using a human breast cancer xenograft model at an orthotopic site in the mouse. Using this method, we screened a set of metabolic genes associated with aggressive breast cancer and stemness to identify those required for in vivo tumorigenesis. Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic region of recurrent copy number gain in breast cancer and PHGDH protein levels are elevated in 70% of oestrogen receptor (ER)-negative breast cancers. PHGDH catalyses the first step in the serine biosynthesis pathway, and breast cancer cells with high PHGDH expression have increased serine synthesis flux. Suppression of PHGDH in cell lines with elevated PHGDH expression, but not in those without, causes a strong decrease in cell proliferation and a reduction in serine synthesis. We find that PHGDH suppression does not affect intracellular serine levels, but causes a drop in the levels of α-ketoglutarate, another output of the pathway and a tricarboxylic acid (TCA) cycle intermediate. In cells with high PHGDH expression, the serine synthesis pathway contributes approximately 50% of the total anaplerotic flux of glutamine into the TCA cycle. These results reveal that certain breast cancers are dependent upon increased serine pathway flux caused by PHGDH overexpression and demonstrate the utility of in vivo negative-selection RNAi screens for finding potential anticancer targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Functional PHGDH loss is toxic to tumor cells with PHGDH amplification or high serine biosynthetic flux (Locasale et al., 2011; Mattaini et al., 2015; Possemato et al., 2011; Zhang et al., 2017), and small-molecule inhibitors targeting PHGDH have been shown to inhibit serine synthesis and tumor proliferation in vitro and in xenograft cancer models (Mullarky et al., 2016; Pacold et al., 2016; Wang”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Serine is present in plasma and can be taken up by cells via amino acid transporters, yet PHGDH expression and increased serine biosynthesis have been shown to be important for supporting cancer cell proliferation and survival in both in vitro and in vivo settings (Locasale et al., 2011; Possemato et al., 2011).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Increased PHGDH gene expression leads to greater production of serine from glucose and is associated with specific subsets of breast cancer, lung adenocarcinoma, and melanoma (Locasale et al., 2011; Possemato et al., 2011; Zhang et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“More recently, it was found that increased expression of the serine synthesis enzyme phosphoglycerate dehydrogenase (PHGDH) in some cancers can result from copy number gain of a region on chromosome 1p (Beroukhim et al., 2010; Locasale et al., 2011; Possemato et al., 2011) or a consequence of oncogenic signaling, including NRF2 and ATF4 signaling (DeNicola et al., 2015), or hypoxia responses (Sam”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Possemato et al., 2011
In the citing paper
“Amplification of PHGDH has been observed in breast cancer and melanoma (65), and increased PHGDH expression can promote both enhanced serine biosynthesis and the proliferation of cancer cells (65, 66).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [66]
In the citing paper
“the region of chromosome 1p12 encoding PHGDH is amplified in a significant fraction of tumors”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
In the citing paper
“cell lines derived from these tumors tend to be highly dependent on PHGDH expression”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Self-citationDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
Self-citationCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation (1,2).”
Self-citationRhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Self-citationDissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J. H., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,515
Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells
Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, S. E., Guenther, M. G., Johnston, W. K., Wernig, M., Newman, J. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.020 · Cited by 1,405
Cited by
Sorted by citations
Items 501–600 of 1,000
Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth
Parnell, K. M., Foulks, J. M., Nix, R. N., Clifford, A., Bullough, J., LUO, B. H., Senina, A. V., Vollmer, D., Liu, J., McCarthy, V., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0026 · Cited by 73
Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism
Nemajerová, A., Amelio, I., Gebel, J., Dötsch, V., Melino, G., & Moll, U. M. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.178 · Cited by 72
Shen, N., Korm, S., Karantanos, T., Li, D., Zhang, X., Ritou, E., Xu, H., Lam, A., English, J., Zong, W., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02805-8 · Cited by 72
Control of cell metabolism by the epidermal growth factor receptor
Orofiamma, L. A., Vural, D., & Antonescu, C. N. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119359 · Cited by 73
NF-Y activates genes of metabolic pathways altered in cancer cells
Benatti, P., Chiaramonte, M. L., Lorenzo, M., Hartley, J. A., Hochhauser, D., Gnesutta, N., Mantovani, R., Imbriano, C., & Dolfini, D. (2015) · Oncotarget · doi:10.18632/oncotarget.6453 · Cited by 72
α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH)
Ravez, S., Corbet, C., Spillier, Q., Dutu, A., Robin, A. D., Mullarky, E., Cantley, L. C., Féron, O., & Frédérick, R. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01166 · Cited by 72
D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation
Okada, A., Nangaku, M., Jao, T., Maekawa, H., Ishimono, Y., Kawakami, T., & Inagi, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11049-8 · Cited by 72
Sánchez‐Martínez, R., Cruz-Gil, S., García-Álvarez, M. S., Reglero, G., & de Molina, A. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11612-3 · Cited by 72
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Bel’skaya, L. V., & Dyachenko, E. I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050282 · Cited by 71
Bridging epigenetics and metabolism
Phang, J. M., Liu, W., & Hancock, C. N. (2013) · Epigenetics · doi:10.4161/epi.24042 · Cited by 71
Functional Characterization of the Plastidial 3-Phosphoglycerate Dehydrogenase Family in Arabidopsis
Toujani, W., Muñoz‐Bertomeu, J., Flores‐Tornero, M., Rosa‐Téllez, S., Anoman, A. D., Alseekh, S., Fernie, A. R., & Ros, R. (2013) · PLANT PHYSIOLOGY · doi:10.1104/pp.113.226720 · Cited by 71
Lin, T.-C., Chen, Y., Kensicki, E., Li, A. Y. J., Kong, M., Li, Y., Mohney, R. P., Shen, H., Stiles, B. L., Mizushima, N., et al. (2012) · Autophagy · doi:10.4161/auto.21228 · Cited by 71
Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
Londhe, P., Yu, P. Y., Ijiri, Y., Ladner, K. J., Fenger, J. M., London, C. A., Houghton, P. J., & Guttridge, D. C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00104 · Cited by 71
Wang, C., Wan, X., Yu, T., Huang, Z., Shen, C., Qi, Q., Xiang, S., Chen, X., Arbely, E., Ling, Z.-Q., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108021 · Cited by 70
Metabolic signatures of human breast cancer
Mishra, P., & Ambs, S. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.992217 · Cited by 70
Lin, C., Zhang, Y., Chen, Y., Bai, Y., & Zhang, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1352-4 · Cited by 70
RetractedDeterminants of nutrient limitation in cancer
Sullivan, M. R., & Heiden, M. G. V. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1611733 · Cited by 70
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation
Dalton, W. B., Helmenstine, E., Walsh, N., Gondek, L. P., Kelkar, D. S., Read, A., Natrajan, R., Christenson, E. S., Román, B., Das, S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125022 · Cited by 70
Role of tyrosine phosphorylation in modulating cancer cell metabolism
Taddei, M. L., Pardella, E., Pranzini, E., Raugei, G., & Paoli, P. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188442 · Cited by 70
Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models
He, X., Wan, J., Yang, X., Zhang, X., Huang, D., Xie, L., Zou, Y., Chen, C., Yu, Z., Xie, L., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140242 · Cited by 70
Regulation of Ferroptosis by Amino Acid Metabolism in Cancer
Yang, J., Dai, X., Xu, H., Tang, Q., & Bi, F. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.64982 · Cited by 70
Dysregulated metabolic enzymes and metabolic�reprogramming in cancer cells (Review)
Sreedhar, A., & Zhao, Y. (2017) · Biomedical Reports · doi:10.3892/br.2017.1022 · Cited by 71
Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth
Mukha, D., Fokra, M., Feldman, A., Sarvin, B., Sarvin, N., Nevo-Dinur, K., Besser, E., Hallo, E., Aizenshtein, E., Schug, Z. T., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.006 · Cited by 69
Selenium Deficiency Is Associated with Pro-longevity Mechanisms
Yim, S. H., Clish, C. B., & Gladyshev, V. N. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.001 · Cited by 69
Chaudhary, V., Kioon, M. D. A., Hwang, S., Mishra, B., Lakin, K. S., Kirou, K. A., Zhang-Sun, J., Wiseman, R. L., Spiera, R., Crow, M. K., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221085 · Cited by 69
Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux
Ost, M., Keipert, S., van Schothorst, E. M., Donner, V., van der Stelt, I., Kipp, A. P., Petzke, K., Jové, M., Pamplona, R., Portero‐Otín, M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-261503 · Cited by 69
Rahman, A. M. A., Pawling, J., Ryczko, M. C., Caudy, A. A., & Dennis, J. W. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.06.012 · Cited by 69
Site-specific metabolic phenotypes in metastatic breast cancer
Kim, H. M., Jung, W. H., & Koo, J. S. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0354-3 · Cited by 69
Dong, W., Keibler, M. A., & Stephanopoulos, G. N. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.02.002 · Cited by 69
Ghergurovich, J. M., Lang, J. D., Levin, M. K., Briones, N., Facista, S. J., Mueller, C., Cowan, A. J., McBride, M. J., Rodriguez, E. S. R., Killian, A. D., et al. (2021) · Med · doi:10.1016/j.medj.2021.03.009 · Cited by 68
Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson
Birsoy, K., Sabatini, D. M., & Possemato, R. (2012) · Nature Medicine · doi:10.1038/nm.2870 · Cited by 68
Self-citationPolet, F., Corbet, C., Pinto, A., Rubio, L. I., Martherus, R., Bol, V., Drozak, X., Grégoire, V., Riant, O., & Féron, O. (2015) · Oncotarget · doi:10.18632/oncotarget.6426 · Cited by 68
A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis
Hu, F., Zeng, W., & Liu, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225720 · Cited by 68
Di Marcantonio, D., Martinez, E., Kanefsky, J. S., Huhn, J. M., Gabbasov, R., Gupta, A., Krais, J. J., Peri, S., Tan, Y., Skorski, T., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.05.008 · Cited by 67
Cycling back to folate metabolism in cancer
Lee, Y., Vousden, K. H., & Hennequart, M. (2024) · Nature Cancer · doi:10.1038/s43018-024-00739-8 · Cited by 68
Mitochondrial mutations and metabolic adaptation in pancreatic cancer
Initiative, A. P. C. G., Hardie, R., van Dam, E., Cowley, M. J., Han, T.-L., Balaban, S., Pajic, M., Pinese, M., Iconomou, M., Shearer, R. F., et al. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0164-1 · Cited by 69
EMT-induced metabolite signature identifies poor clinical outcome
Bhowmik, S. K., Ramirez‐Peña, E., Arnold, J. M., Putluri, V., Sphyris, N., Michailidis, G. C., Putluri, N., Ambs, S., Sreekumar, A., & Mani, S. A. (2015) · Oncotarget · doi:10.18632/oncotarget.4765 · Cited by 66
Metcalf, S. A., Dougherty, S. M., Kruer, T. L., Hasan, N., Biyik‐Sit, R., Reynolds, L., & Clem, B. F. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-10000-7 · Cited by 66
Role of Mitochondrial Stress Response in Cancer Progression
Lee, Y. G., Park, D. H., & Chae, Y. C. (2022) · Cells · doi:10.3390/cells11050771 · Cited by 67
The Warburg effect on radioresistance: Survival beyond growth
Kang, H., Kim, B., Park, J., Youn, H., & Youn, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188988 · Cited by 67
HiTSelect: a comprehensive tool for high-complexity-pooled screen analysis
Diaz, A. A., Qin, H., Ramalho‐Santos, M., & Song, J. S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1197 · Cited by 66
Phannasil, P., Ansari, I. H., Azzouny, M. E., Longacre, M. J., Rattanapornsompong, K., Burant, C., MacDonald, M. J., & Jitrapakdee, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.021 · Cited by 66
Yan, K., Xu, X., Wu, T., Li, J., Cao, G., Li, Y., & Zongzheng, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.059 · Cited by 66
Parsa, S., Ortega-Molina, A., Ying, H., Jiang, M., Teater, M. R., Wang, J., Zhao, C., Reznik, E., Pasion, J. P., Kuo, D. C., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0080-0 · Cited by 66
Self-citationThe PHGDH enigma: Do cancer cells only need serine or also a redox modulator?
Li, A. M., & Ye, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.036 · Cited by 65
Overview of Cancer Metabolism and Signaling Transduction
Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 66
Stegen, S., Moermans, K., Stockmans, I., Thienpont, B., & Carmeliet, G. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00948-y · Cited by 65
Noh, S., Kim, D. H., Jung, W. H., & Koo, J. S. (2014) · Tumor Biology · doi:10.1007/s13277-013-1588-z · Cited by 65
Self-citationThe role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 65
Deciphering metabolic rewiring in breast cancer subtypes
Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 67
SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism
Chen, S., Yang, X. P., Yu, M., Wang, Z., Liu, B., Liu, M., Liu, L., Ren, M., Qi, H., Zou, J., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2019.04.008 · Cited by 65
Cancer metabolism and intervention therapy
Zhao, H., & Li, Y. (2021) · Molecular Biomedicine · doi:10.1186/s43556-020-00012-1 · Cited by 67
Gámez‐Pozo, A., Berges‐Soria, J., Arevalillo, J. M., Nanni, P., López‐Vacas, R., Navarro, H., Grossmann, J., Castañeda, C. A., Maı́n, P., Díaz‐Almirón, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1937 · Cited by 64
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Burkhart, R. A., Pineda, D. M., Chand, S. N., Romeo, C., Londin, E. R., Karoly, E. D., Cozzitorto, J. A., Rigoutsos, I., Yeo, C. J., Brody, J. R., et al. (2013) · RNA Biology · doi:10.4161/rna.25274 · Cited by 64
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
Panwalkar, P., Tamrazi, B., Dang, D., Chung, C., Sweha, S. R., Natarajan, S. K., Pun, M. J., Bayliss, J. M., Ogrodzinski, M. P., Pratt, D. W., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0497 · Cited by 63
Glutamine addiction promotes glucose oxidation in triple-negative breast cancer
Quek, L., van Geldermalsen, M., Guan, Y. F., Wahi, K., Mayoh, C., Balaban, S., Pang, A., Wang, Q., Cowley, M. J., Brown, K., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02408-5 · Cited by 63
Sato, M., Kawana, K., Adachi, K., Fujimoto, A., Yoshida, M., Nakamura, H., Nishida, H., Inoue, T., Taguchi, A., Takahashi, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8947 · Cited by 63
Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
Zhao, J., Li, J., Fan, T. W. ‐., & Hou, X. S. (2017) · Oncotarget · doi:10.18632/oncotarget.18787 · Cited by 63
Control of the Antitumor Immune Response by Cancer Metabolism
Domblides, C., Lartigue, L., & Faustin, B. (2019) · Cells · doi:10.3390/cells8020104 · Cited by 64
Mullarky, E., Xu, J., Robin, A. D., Huggins, D. J., Jennings, A. J., Noguchi, N., Olland, A. M., Damodharan, L., Miller, M. J., Tomita, D., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.011 · Cited by 63
Wu, X., Xia, J., Zhang, J., Zhu, Y., Wu, Y., Guo, J., Chen, S., Lei, Q., Meng, B., Kuang, C., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16503 · Cited by 63
Spillier, Q., Vertommen, D., Ravez, S., Marteau, R., Thémans, Q., Corbet, C., Feron, O., Wouters, J., & Frédérick, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-41187-0 · Cited by 62
Alcohol and DNA Methylation: An Epigenome-Wide Association Study in Blood and Normal Breast Tissue
Wilson, L. E., Xu, Z., Harlid, S., White, A. J., Troester, M. A., Sandler, D. P., & Taylor, J. A. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz032 · Cited by 62
Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling
Chen, C., Zhu, T., Liu, X., Zhu, D., Zhang, Y., Wu, S., Han, C., Zhang, H., Luo, J., & Kong, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.008 · Cited by 62
Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis
Zeng, Y., Zhang, J., Xu, M., Chen, F., Zi, R., Yue, J., Zhang, Y., Chen, N., & Chin, Y. E. (2021) · Journal of Cancer · doi:10.7150/jca.60170 · Cited by 62
Hennequart, M., Labuschagne, C. F., Tajan, M., Pilley, S. E., Cheung, E. C., Legrave, N. M., Driscoll, P. C., & Vousden, K. H. (2021) · Nature Communications · doi:10.1038/s41467-021-26395-5 · Cited by 62
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy
Chen, C., Wang, Z., & Qin, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935536 · Cited by 62
Ferroptosis and its role in skeletal muscle diseases
Wang, Y., Zhang, Z., Jiao, W., Wang, Y., Wang, X., Zhao, Y., Fan, X., Tian, L., Li, X., & Mi, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1051866 · Cited by 62
Zhang, J., Wei, H., Liu, X., Wang, N., Qi, Y., Zhang, Y., & Shulan, Z. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1017690 · Cited by 62
Eutrophication and the dietary promotion of sea turtle tumors
Houtan, K. S. V., Smith, C. M., Dailer, M. L., & Kawachi, M. S. (2014) · PeerJ · doi:10.7717/peerj.602 · Cited by 62
di Salvo, M. L., Contestabile, R., Paiardini, A., & Maras, B. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.02.008 · Cited by 62
Similarities in the Metabolic Reprogramming of Immune System and Endothelium
Tang, C.-Y., & Mauro, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00837 · Cited by 62
Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
Yu, X., Ma, R., Wu, Y., Zhai, Y., & Li, S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00394 · Cited by 64
Li, S., Hong, Y., Wan, L., Liu, J.-Y., Ren, L., Yang, Y., Ge, B., Zhang, Y., Fu, W.-Q., Zheng, X., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00894-7 · Cited by 61
Rosa‐Téllez, S., Alcántara‐Enguídanos, A., Martínez-Seidel, F., Casatejada‐Anchel, R., Saeheng, S., Bailes, C., Erban, A., Medeiros, D. B., Alepuz, P. M., Matus, J. T., et al. (2023) · The Plant Cell · doi:10.1093/plcell/koad256 · Cited by 61
EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma
Tanner, J. M., Bensard, C., Wei, P., Krah, N. M., Schell, J. C., Gardiner, J. D., Schiffman, J. D., Lessnick, S. L., & Rutter, J. P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0182 · Cited by 61
Strmiska, V., Michálek, P., Eckschlager, T., Stiborová, M., Adam, V., Křížková, S., & Heger, Z. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.001 · Cited by 62
Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance
Nwosu, Z. C., Piorońska, W., Battello, N., Zimmer, A. D., Dewidar, B., Han, M., Pereira, S., Blagojevic, B., Castven, D., Charlestin, V., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102699 · Cited by 61
Bogner, A. N., Stiers, K. M., & Tanner, J. J. (2021) · Amino Acids · doi:10.1007/s00726-021-02999-5 · Cited by 60
Yamamoto, T., Hayashida, T., Masugi, Y., Oshikawa, K., Hayakawa, N., Itoh, M., Nishime, C., Suzuki, M., Nagayama, A., Kawai, Y., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2266 · Cited by 60
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
Cuyàs, E., Fernández‐Arroyo, S., Corominas-Faja, B., Rodríguez‐Gallego, E., Bosch‐Barrera, J., Martı́n-Castillo, B., Llorens, R., Joven, J., & Menéndez, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.3733 · Cited by 60
Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma
Hettmer, S., Schinzel, A. C., Tchessalova, D., Schneider, M., Parker, C. L., Bronson, R. T., Richards, N. G. J., Hahn, W. C., & Wagers, A. J. (2015) · eLife · doi:10.7554/elife.09436 · Cited by 60
Bayraktar, E. C., La, K., Karpman, K., Unlu, G., Ozerdem, C., Ritter, D. J., Alwaseem, H., Molina, H., Hoffmann, H.-H., Millner, A., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0206-9 · Cited by 60
Self-citationArnold, J. M., Gu, F., Ambati, C. R., Rasaily, U., Ramirez‐Peña, E., Joseph, R., Manikkam, M., Martin, R. S., Charles, C., Pan, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0885-4 · Cited by 59
Oncology Therapeutics Targeting the Metabolism of Amino Acids
Muhammad, N., Lee, H. M., & Kim, J. (2020) · Cells · doi:10.3390/cells9081904 · Cited by 59
Yu, T., Liu, Y., Li, X., Lian, B., Lu, X., Jin, X., Shao, Z., Hu, X., Di, G., & Jiang, Y. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0747 · Cited by 59
Wang, T., Dang, N., Tang, G., Li, Z., Li, X., Shi, B., Xu, Z., Li, L., Yang, X., Xu, C., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13190 · Cited by 59
Benichou, E., Seffou, B., Topçu, S., Renoult, O., Lenoir, V., Planchais, J., Bonner, C., Postic, C., Prip‐Buus, C., Pecqueur, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45548-w · Cited by 59
Cysteine protease enhances plant-mediated bollworm RNA interference
Mao, Y., Xue, X., Tao, X., Yang, C., Wang, L.-J., & Chen, X. (2013) · Plant Molecular Biology · doi:10.1007/s11103-013-0030-7 · Cited by 59
Kong, L., Xue, M., Zhang, Q.-C., & Su, C.-F. (2017) · Oncotarget · doi:10.18632/oncotarget.14662 · Cited by 59
RetractedPadrón-Barthe, L., Villalba‐Orero, M., Gómez-Salinero, J. M., Acín‐Pérez, R., Cogliati, S., López-Olañeta, M. M., Ortiz-Sánchez, P., Bonzón‐Kulichenko, E., Vázquez, J., García‐Pavía, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.067 · Cited by 59
Białopiotrowicz, E., Noyszewska‐Kania, M., Kachamakova‐Trojanowska, N., Łoboda, A., Cybulska, M., Grochowska, A., Kopczyński, M., Mikuła, M., Prochorec‐Sobieszek, M., Firczuk, M., et al. (2020) · Cancers · doi:10.3390/cancers12030580 · Cited by 59
Zheng, X., Ma, H., Wang, J., Huang, M., Fu, D., Qin, L., & Yin, Q. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101534 · Cited by 59
Gu, L., Zhu, Y., Lin, X., Li, Y., Cui, K., Prochownik, E. V., & Li, Y. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0340 · Cited by 58
Metabolism and immunity in breast cancer
Zhang, D., Xu, X., & Ye, Q. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0793-6 · Cited by 58
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57
The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024) · Research · doi:10.34133/research.0351 · Cited by 57
Proliferation and tissue remodeling in cancer: the hallmarks revisited
Markert, E. K., Levine, A. J., & Vázquez, A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.140 · Cited by 57
Changing appetites: the adaptive advantages of fuel choice
Stanley, I. A., Ribeiro, S. M., Giménez-Cassina, A., Norberg, E., & Danial, N. N. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.010 · Cited by 57
Metadata
- Authors
- Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., Chen, W. W., Barrett, F. G., Stransky, N., Tsun, Z.-Y., Cowley, G. S., Barretina, J., Kalaany, N. Y., Hsu, P. P., Ottina, K., Chan, A. M., Yuan, B., Garraway, L. A., Root, D. E., Mino-Kenudson, M., Brachtel, E. F., Driggers, E. M., & Sabatini, D. M.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Agios Pharmaceuticals (United States) (US)
- Broad Institute (US)
- Harvard University (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Possemato, Richard
- Shaul, Yoav D.
- Pacold, Michael E.
- Kim, Dohoon
- Birsoy, Kıvanç
- Sethumadhavan, Shalini
- Jang, Hyun G.
- Jha, Abhishek K.
- Chen, Walter W.
- Barrett, Francesca G.
- Stransky, Nicolas
- Cowley, Glenn S.
- Barretina, Jordi
- Kalaany, Nada Y.
- Hsu, Peggy P.
- Yuan, Bingbing
- Garraway, Levi A.
- Root, David E.
- Mino-Kenudson, Mari
- Brachtel, Elena F.
- Sabatini, David M.
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7360
- Pages
- 346-350
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3353325
- OpenAlex
- W2022899908
- Cited by
- 1,683
- References
- 27
- Citations by year
- 2026: 72 · 2025: 111 · 2024: 120 · 2023: 116 · 2022: 138 · 2021: 167 · 2020: 137 · 2019: 126 · 2018: 93 · 2017: 97 · 2016: 125 · 2015: 93 · 2014: 109 · 2013: 72 · 2012: 87
- FWCI
- 31.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- W. M. Keck Foundation
- Alexander and Margaret Stewart Trust
- Life Sciences Research Foundation
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health
- National Cancer Institute (CA103866, R01CA103866, R01CA129105)
- National Institute of General Medical Sciences (T32GM007753)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- PHGDH, breast cancer, cancer metabolism, breast cancer xenografts, estrogen receptor-negative breast cancer, alpha-ketoglutarate, glutamine metabolism, TCA cycle, anaplerosis, tumor metabolic reprogramming, anticancer drug targets, cell proliferation
- MeSH terms
- Animals, Breast Neoplasms, Citric Acid Cycle, Humans, Ketoglutaric Acids, Melanoma, Neoplasm Transplantation, Serine, Biomarkers, Tumor, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glutamic Acid, Genomics, RNA Interference, Cell Line, Tumor, Cell Proliferation, Phosphoglycerate Dehydrogenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
